Non-inflammatory pain in inflammatory arthritis.

Publication Year: 2023

DOI:
10.1093/rheumatology/keac671

PMCID:
PMC10321089

PMID:
36478185

Journal Information

Full Title: Rheumatology (Oxford)

Abbreviation: Rheumatology (Oxford)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Rheumatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure statement: E.C. has received research grants and/or served as a member of advisory boards and speaker bureaus of Abbvie, Amgen, Bio-Cancer, Biogen, Bristol Myer Squibbs, Celgene, Chugai Pharma, Eli Lilly, Fresenius Kai, Gilead, Galapagos, Inmedix, Janssen, Novartis, ObsEva, Pfizer, Regeneron, Roche, R-Pharm, Sanofi, SynAct Pharma, and UCB. D.D. has no conflict of interest."

Evidence found in paper:

"Funding No direct funding has been received for this work. The CREATE Centre was established by grant awards from Versus Arthritis and Health and Care Research Wales (20016). Disclosure statement: E.C. has received research grants and/or served as a member of advisory boards and speaker bureaus of Abbvie, Amgen, Bio-Cancer, Biogen, Bristol Myer Squibbs, Celgene, Chugai Pharma, Eli Lilly, Fresenius Kai, Gilead, Galapagos, Inmedix, Janssen, Novartis, ObsEva, Pfizer, Regeneron, Roche, R-Pharm, Sanofi, SynAct Pharma, and UCB. D.D. has no conflict of interest."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025